Onkar N. Singh
16Patents
8h-index
31Co-inventors
72Inventor score
Filing activity: Aug 10, 2000 → Oct 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7001615B1 | Sustained release ophthalmic, otic and nasal suspension | Human Necessities | 81 | Expired |
| US6284804A | Topical suspension formulations containing ciprofloxacin and dexamethasone | Human Necessities | 43 | Expired |
| US6359016B2 | Topical suspension formulations containing ciprofloxacin and dexamethasone | Human Necessities | 30 | Expired |
| US8791154B2 | High concentration olopatadine ophthalmic composition | Chemistry; Metallurgy | 27 | Active |
| US7977376B2 | Olopatadine formulations for topical nasal administration | Emerging Cross-Sectional Technologies | 22 | Active |
| US8399508B2 | Olopatadine formulations for topical nasal administration | Emerging Cross-Sectional Technologies | 19 | Active |
| US6995186B2 | Olopatadine formulations for topical administration | Human Necessities | 15 | Expired |
| US6486208B1 | Sustained release, and comfortable opthalmic composition and method for ocular therapy | Human Necessities | 13 | Expired |
| US7888370B2 | Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate | Human Necessities | 4 | Active |
| US6462033B2 | Process for manufacturing compositions containing ciprofloxacin and hydrocortisone | Human Necessities | 2 | Expired |
| US8173671B2 | Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate | Human Necessities | 2 | Active |
| US9662334B2 | Sildenafil sublingual spray formulations | Human Necessities | 1 | Active |
| US7402609B2 | Olopatadine formulations for topical administration | Human Necessities | 1 | Expired |
| US10111833B2 | Sildenafil sublingual spray formulations | Human Necessities | 0 | Active |
| US12370203B2 | Pharmaceutical compositions and methods of making on demand solid dosage formulations | Human Necessities | 0 | Active |
| US9533053B2 | High concentration olopatadine ophthalmic composition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.